ANTIGEN BINDING FRAGMENTS, DESIGNATED 4B5, THAT SPECIFICALLY DETECT CANCER CELLS, NUCLEOTIDES ENCODING THE FRAGMENTS, AND USE THEREOF FOR THE PROPHYLAXIS AND DETECTION OF CANCERS - Patent 1000082

(19)

(11)

EP 1 000 082 A2

(12)

(88)	Date of publication A3:
	01.04.1999

(43)	Date of publication:
	17.05.2000 Bulletin 2000/20

(21)	Application number: 98929569.6

(22)	Date of filing: 08.07.1998

(51)	International Patent Classification (IPC)⁷: C07H 21/00

(86)	International application number:
	PCT/IB9801/046

(87)	International publication number:
	WO 9902/545 (21.01.1999 Gazette 1999/03)

(84)	Designated Contracting States:
	AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

(30)

Priority:

08.07.1997 US 51945 P

(71)	Applicant: Novopharm Biotech, Inc.
	Winnipeg, Manitoba R3T 3Z1 (CA)

(72)	Inventors:
	DAN, Michael, D. Scarborough, Ontario M1B 2K9 (CA) SALEH, Mansoor, N. Marrietta, GA 30068 (US) NASOFF, Marc, S. San Diego, CA 92131 (US)

(74)	Representative: Meissner, Bolte & Partner
	Anwaltssozietät GbRPostfach 86 06 24 81633 München 81633 München (DE)

(54)	ANTIGEN BINDING FRAGMENTS, DESIGNATED 4B5, THAT SPECIFICALLY DETECT CANCER CELLS, NUCLEOTIDES ENCODING THE FRAGMENTS, AND USE THEREOF FOR THE PROPHYLAXIS AND DETECTION OF CANCERS